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 2 
Abstract 
Fab’ fragments have become an established class of biotherapeutic over the last two 
decades. Likewise, developments in synthetic biology are providing ever more powerful 
techniques for designing bacterial genes, gene networks and entire genomes that can be 
used to the improve industrial performance of cells used for production of biotherapeutics. 
We have previously observed significant leakage of an exogenous therapeutic Fab’ fragment 
into the growth medium during high cell density cultivation of an Escherichia coli production 
strain. In this study we sought to apply a promoter engineering strategy to address the issue 
of Fab’ fragment leakage and its consequent bioprocess challenges. We used site directed 
mutagenesis to convert the Ptac promoter, present in the plasmid, pTTOD-A33 Fab’, to a Ptic 
promoter which has been shown by others to direct expression at a 35% reduced rate 
compared to Ptac. We characterised the resultant production trains in which either Ptic or Ptac 
promoters direct Fab’ fragment expression. The Ptic promoter strain showed a 25-30% 
reduction in Fab’ expression relative to the original Ptac strain. Reduced Fab’ leakage and 
increased viability over the course of a fed-batch fermentation were also observed for the Ptic 
promoter strain. We conclude that cell design steps such as the Ptac to Ptic promoter 
conversion reported here, can yield significant process benefit and understanding with 
respect to periplasmic Fab’ fragment production. It remains an open question as to whether 
the influence of transgene expression on periplasmic retention is mediated by global 
metabolic burden effects or periplasm overcapacity. 
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Introduction  
Mammalian proteins rarely achieve native folding when expressed exogenously in E. coli. 
This fact presents a particularly acute challenge for those seeking to harvest such proteins 
from E. coli for use as medicines. Typically, when mammalian transgenes are transcribed 
and translated in the E. coli cytosol nascent polypeptide chains bundle together in 
homoaggregates known as inclusion bodies (IBs). Such IBs require extensive bioprocess 
recovery steps before an active protein is obtained. A major factor that can drive IB 
formation in E. coli is the absence of the molecular machinery needed to perform 
mammalian post-translational modifications (PTM). In mammalian cells PTMs often involve 
incorporation of small molecule or carbohydrate moieties whose presence is necessary to 
achieve native folding. The absence of native folding then favours IB formation. 
As well as their own misfolding, the overexpression of exogenous proteins by E. coli can 
also have deleterious global effects on the host cell. Activation of DNA distress ‘SOS’ 
response systems (1) and even apoptosis-like death (2,3) have been observed to occur as a 
direct result of the burdens caused by overexpression of exogenous proteins. 
A number of approaches have emerged to reduce the overall expression level of exogenous 
proteins encoded by transgenes within recombinant plasmids, whilst at the same time 
maxmising recombinant protein yield and quality. Since the 1980s, plasmids whose origin of 
replication (ori) defines a high copy number have been a boon to molecular biology as they 
provide the high yields of plasmid DNA (pDNA) needed to facilitate DNA recombination 
procedures while having little physiological impact on cells grown in shake flasks. 
Meanwhile, low copy number plasmids have remained prevalent in industrial application 
because they tend to direct levels of transgene expression that are better tolerated by cells 
already pushed close to their metabolic limits by cultivation to high cell density in bioreactors.  
Choice of plasmid copy number for fine-tuning recombinant protein expression level is 
limited because, as yet, there is no library of oris with incrementally inreasing copy numbers. 
Instead only a small set of plasmid oris is avialable, with quite large steps in copy number 
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between oris, from 20 to 300 for instance. Typically, a given ori will direct a very broad range 
of copy number, from 300 to 500, depending on transgenes and host strain (30).  
Another option for minimising metabolic burden on host cells is to avoid the classic setup 
whereby cells face an antibiotic challenge, which they must meet by expression of an 
exogenous antibiotic resistance gene present on a retained plasmid. Expression of such 
antibiotic resistance genes inevitably tends to contribute to the metabolic burden exerted by 
the plasmid. Antibiotic resistance transgenes can be replaced with an endogenous gene 
encoding a protein that performs an essential function within the host cell metabolism. 
Inactivation of the copy of the essential gene in the host cell genome makes retention of the 
plasmid essential for cell survival (31). For recombinant protein production, this ‘auxotrophic 
complementation’ approach thas shown promise at shake flask scale but investigations in 
bioreactors remain rare (32), as do studies at high cell density (OD600 > 100). 
Biotechnologists designing plasmids for industrial production of recombinant proteins should 
consider both plasmid copy number and the selective pressure used to ensure plasmid 
retention. An additional design feature to consider is the choice of promoter uses to control 
transgene expression. Yakandawala et al. found that transgene expression with the strong 
T7 promoter resulted in up to 99.5% reduction in the abundance of certain E. coli 
housekeeping mRNA molecules through MazEF activation, whereas lower level expression 
driven by a T5 promoter caused no perturbation of host mRNAs (3). Interestingly, the MazEF 
endoribonuclease can be employed to down-regulate host cell protein production in order to 
simplify downstream processing and an expression system that exploits this function has 
been commercialised (4). 
A common strategy for avoiding cytosolic IB formation and promoting correct folding of 
exogenous proteins is to genetically append them to short E. coli amino terminal peptides 
that signal transport to the periplasmic space (5). The process of translocation to the 
periplasm can even in some cases select for correct folding (6). Once inside the periplasm 
the oxidative environment enables disulphide bond formation and any subsequent folding 
events favoured by the presence of those bonds.  
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In addition to periplasmic targeting, many researchers have attempted to balance the level of 
transgene expression driven by transgenic promoters with the global capacity of the host cell 
to replicate DNA, transcribe DNA to RNA, translate RNA to protein and translocate protein 
across membranes (33). Such balancing, or harmonisation, of promoter strength can be 
critical for efficient translocation of periplasm-targeted proteins. Excessive expression leads 
to crowding of transolocons, the transport machineries that mediate transport back and forth 
between the cytosol and periplasm. This in turn can lead to translocation failure and 
inclusion body formation (7). Options to address these issues include decreasing transgene 
translation rate (8), choosing alternative trafficking pathways to exploit (9,10) and employing 
MazEF activation to globally downregulate expression of those host cell proteins native to 
the periplasm and outer membrane that constitute a competing load on the capacity of 
translocons (11).  
Balancing promoter strength with the overall metabolic burden of cellular 'housekeeping' 
processes could allow also address translocon overload caused by periplasmic translocation 
of exogenous proteins. In this way promoter engineering can be used to indirectly remodel 
trafficking events. In elegant work with two different recobinant proteins trafficked to the 
periplasm via the same route, Schlegel et al. showed that gene expression above a certain 
threshold can saturate the Sec-translocon capacity (33). Promoter engineering has been 
employed by synthetic biologists to improve biofuel production (12), optimise synthetic gene 
network performance (13) and enable construction of novel genetic logic gates (14). For 
instance, engineering the promoters encoded by a plasmid to control expression of an 
antibiotic resistance marker and the lacI repressor resulted in a four-fold increase in 
recombinant protein production at shake flask scale (15).  
The tools and approaches developed in synthetic biology, such as genome refactoring (16), 
represent a potentially powerful new route to improved industrially relevant scale 
performance by harmonising promoter design with engineering application. Song et al. (17) 
provide a notable example where they developed a bacterial strain for production of 3-
aminopropionic acid (3APA). Firstly they refactored a multi-gene locus from 
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Corynebacterium glutamicum (C. glutamicum) which includes the panD gene for an L-
aspartate-α-decarboxylase. All the native C. glutamicum promoters within this locus were 
substituted with defined and designed synthetic promoters to enhance control and minimize 
epistatic cross talk and feedback effects. Finally the engineered locus was ported en bloc 
into an E. coli strain previously modified to produce fumaric acid. The final, engineered strain 
achieved yields of 32.3 g/L 3APA in fed-batch fermentation (17). Similarly, in the yeast 
Pichia pastoris, the highest ever yield of 18 g/L of active, secreted, recombinant cellulase to 
date was achieved by integrating the design of the cell cultivation programme and the design 
of the promoter used to control transgene expression (18).  
For the workhorse strain of the biotechnology industry, E. coli, the most commonly utilised 
promoters were originally designed and assembled using genetic elements from the T7 
bacteriophage and elements native to E. coli such as the Plac and Ptrp promoters (19, 20) and 
the lac operon. The resultant synthetic promoters, such as Ptac and Ptrc , are highly active 
when de-repressed by the presence of isopropyl β-D-1-thiogalactopyranoside (IPTG). Ptrc 
differs from Ptac by only a single base insertion between bases at the -10 and -35 positions 
relative to the start codon (20). This alteration impacts the interaction between the -10 and -
35 sites and RNA polymerase and subsequent transcription. The expression dynamics 
arising from another Ptac variant, the Ptic promoter, have been characterised using shake 
flask cultivation by Brosius et al. (20) who determined its activity to be 65% of the parental 
Ptac promoter.   
In this study we seek to address the upstream bioprocess consequences that arise from 
using a highly active promoter, Ptac, to drive expression of a therapeutic Fab' fragment in the 
periplasmic space. We previously (21) observed leakage of Fab' into the cell exterior after 
20-30 hours of Ptac induction. As such we were keen to ascertain if this leakage occurs as a 
consequence of Fab' expression level. Our approach is to mutagenise the Ptac promoter to 
convert it to a Ptic promoter that has been shown by others to drive lower levels of 
transcription. 
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Bäcklund et al. (22) observed that post-induction glycerol feed rate can influence leakage of 
a recombinant Fab' from E. coli cells during 5-8 L bioreactor cultivation in a minimal salt 
medium. This suggests that the metabolic status of the cell may also play a significant role in 
its ability to maintain the integrity of the outer membrane during overexpression of 
exogenous proteins. To shed some light on this we used a flow cytometry approach to 
determine, at different stages of cultivation, the proportion of cells that are healthy and those 
that are non-viable (dead or dying) and have punctured outer membranes.  
We use an industrial protocol for cultivation of cells to high cell density and induction of 
periplasmic Fab' expression using a 7.5 L bioreactor and defined media (21) to compare 
performance of cells in which Fab’ expression is driven either by the Ptac or Ptic promoters. 
We also attempt to determine the point of leakage as a function of the predicted percentage 
occupation of periplasm volume.  
 
Materials and Methods 
All chemicals were purchased from Sigma Chemical Co. Ltd. (Dorset, UK), unless stated 
otherwise, and were of analytical grade. 
Promoter engineering 
The plasmid pTODDA33 (UCB, Brussels, Belgium) encodes a therapeutic Fab' fragment 
under the  control of a Ptac promoter. The Ptac promoter was converted into the Ptic promoter 
described by Brosius et al. (20) by insertion of one cytosine and one guanine base between 
the -10 and -35 regions to extend the spacing by two residues. Forward and reverse primers 
of sequence GCTGTTGACAATTAATCATCGCGGCTCGTATAATGTGTGGAA and 
TTCCACACATTATACGAGCCGCGATGATTAATTGTCAACAGC respectively were used to 
introduce the mutation following the Stratagene QuikChangeTM site directed mutagenesis 
protocol. Plasmids were transformed into the E. coli W3110 strain using standard molecular 
biology techniques (23). 
Fed-batch fermentation and Fab' fragment quantitation 
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The Balasundaram et al. (24) cell cultivation protocol was linearly scaled down for use in 
New Brunswick BioFlo 110 7.5 L bioreactors. Samples were centrifuged to pellet cells and 
supernatant was decanted into a separate vessel and both pellet and supernatant were 
stored overnight (16-20 hours) at -20oC before Fab’ quantitation. The Nesbeth et al. (21) 
procedure was used to assay total and extracellular dimeric Fab’ concentrations by protein G 
HPLC. 
PIX staining and flow cytometry 
Flow cytometry was performed using an Accuri C6 flow cytometer (BD Biosciences, USA) 
with bis-oxonol (BOX) and propidium iodide (PI) stains (PIX). Analysis using this method has 
been described by others (25) as an accurate method to measure cell viability (ability to 
exclude BOX) and permeability (PI uptake). Briefly, fermentation samples were diluted to an 
OD600 of 1.0 and 10 µL combined with 990 µL of a staining solution consisting of 5 µg/mL 
bis-oxonol, 4 mM ethylenediaminetetraacetic acid (EDTA), 2 µg/mL propidium iodide, in 
phosphate-buffered saline (PBS). Samples were stained for 8 minutes before analysis. 
Appropriate compensation was applied to correct for spectral overlap between the stains 
with the BD Accuri C6 software package, and results were gated to exclude cellular and 
other debris. Cells that remained unstained by BOX were counted to provide an overall 
measurement of viable cells/mL; cells which were stained by BOX and PI were counted to 
provide permeable cells/mL measurement. Differences caused by changing biomass levels 
were accounted for by reporting cells per mL per OD600 unit, as previously performed by 
Volkmer et al. (26). Any readings displaying just PI staining were attributed to cell fragments 
and other debris, and discounted from calculations. 
Mathematical modelling of periplasm occupancy 
Concentration of dimer obtained by HPLC analysis was converted into units per cell by using 
Equation 1 and assuming 100% conversion of monomer to correctly folded dimer, with a 
predicted dimer weight of 8.4E10-17 mg/unit and volume of 6.06E10-23 L/unit. The total 
volume of the periplasm is assumed to be 6.5E10-17 L (27).  
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Equation 1. Calculation of percentage periplasm occupancy from Fab' concentration (mg/L); 
cell concentration (cells/L), Fab' weight (mg/unit), volume of Fab' fragment (L/unit), and 
volume of periplasm (L). 
Results and Discussion 
Conversion of Ptac to Ptic 
The addition of two bases, cytosine and a guanine, between the -10 and -35 sites of the Ptac 
promoter (Figure 1) generates the Ptic promoter which was characterised previously at shake 
flask scale with respect to its ability to direct expression of chloramphenicol acetyltransferase 
and E. coli 4.5 S RNA (17). In that study the Ptic promoter showed a 35% decrease in 
expression compared to the parental Ptac promoter when used to express the same ORFs. 
Here we used site directed mutagenesis (SDM) to effect the Ptac to Ptic conversion within the 
pTODD A33 plasmid (21) upstream of the Fab’ fragment heavy and light chain open reading 
frames (ORFs). The insertion mutation was confirmed by sequencing and the Ptic-pTODD 
A33 plasmid was transformed into the E. coli w3110 production strain to produce the Fabi 
strain. The original Ptac-pTODD A33 plasmid was also transformed into w3110 to produce 
the Fab strain.  
Growth and productivity impacts of Ptac to Ptic conversion 
Fermentations were performed according to previously described protocols (24), scaled for 
use in a 7.5 L bioreactor. The Fab and Fabi strains showed similar growth profiles (Figure 2), 
with differences in OD600 attributable to the 20% variation expected between fermentation 
runs (21). For the Fab strain OD600 began to decrease at 88 hours post-inoculation, which is 
48 hours post-induction. OD600 of the Fabi strain decreased 88 hours post-inoculation, 48 
hours post-induction (Figure 2). We interpreted the decrease in OD600 as the onset of cell 
disintegration and death. Total and external Fab’ levels were measured using protein G 
HPLC as previously described (21, 22), and these values used to calculate the internal 
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(Figure 3A) and external (Figure 3B) levels of Fab’ accumulation. Internal Fab’ fragment 
accumulation occurs at a 25-30% slower rate (Figure 3A) for the Fabi strain (0.23 mg Fab’ / 
g cell weight / hour) compared to the Fab strain (0.32 mg Fab’ / g cell weight/ hour). In 
Figure 3B the level of external Fab’ is plotted over both the entire 60 hour post-induction 
period (larger graph) and the first 40 hours only (inset graph). In this post-induction, pre-
death period external Fab’ fragment levels represent 5 – 8 % of total protein (internal and 
external) for the Fabi strain and 10 – 23% for the Fab strain over three experimental repeats. 
Despite the fact that a greater proportion of Fab’ fragment has leaked to the cell exterior for 
the Fab strain, the periplasmic filling profile for both strains is similar (Figure 3C), apart from 
the final time point in which periplasmic Fab’ levels appear apparently decreased. 
Percentage periplasm filling was calculated as described in Equation 1, and both strains 
show a similar increase over time, never exceeding 7%. Moreover, cell populations for both 
strains reach the onset of lysis at 48 hours post induction, when percentage occupancy 
exceeds 6%. This suggests that the maximum space available within the periplasm for 
recombinant protein synthesis is approximately 6% and that beyond this point leakage of 
periplasm contents to the cell exterior is triggered.  
Impeller speed suggests less cell death events with Ptic promoter compared to Ptac 
A number of different mechanisms may explain the appearance of Fab' fragment in the 
growth medium. When over 6% of total periplasm volume is occupied by exogenous protein, 
the outer membrane may rupture in a manner that is fatal to the cell. Alternatively, a pathway 
may exist whereby cells overexpressing exogenous periplasmic Fab' fragment can 'vent' 
Fab' periplasmic contents to the cell exterior in order to counteract the production surplus. 
Theoretically such controlled periplasmic venting (CPV) could be triggered directly by 
detection of internal Fab' levels exceeding a 6% threshold of total periplasmic volume. 
Alternatively, exceeding the 6% threshold may be purely coincidental and CPV could in fact 
be triggered by other factors, such as metabolic burden or unfolded protein response. 
Notwithstanding the triggering mechanism, we sought to differentiate between periplasmic 
rupture and CPV using a selection of experiments.  
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Firstly we attempted to determine the level of cell death that occurs during bioreactor 
cultivation of each strain. For many microbial fermentation processes, including E. coli, 
impeller speed correlates to the oxygenation requirement of a given culture (28). In the 
fermentation protocol used here (21), cells are maintained in carbon-limited idiophasic 
growth post-induction resulting in markedly less oxygen demand than trophophase growth. 
Any significant increase in the viscosity of the cell suspension would not be due to cell 
growth, see post-induction turbidity in Figure 2, would hinder oxygen transfer and thus would 
trigger increased impeller speed due to the operation of proportional-integral-differential 
(PID) algorithms within the bioreactor control unit.  
When E. coli cells die during high cell density cultivation the released intracellular contents, 
particularly the high molecular weight heteropolymeric DNA genome, tend to significantly 
increase the viscosity of the cell suspension through aggregation and other processes (29). 
As no process other than cell growth or release of cell contents is believed to impact 
viscosity, any significant increases in post-induction process stream viscosity can be 
regarded as an indicator of the level of cell contents release, i.e. cell death. Therefore 
impeller speed can in this context be considered as an indirect indicator of cell death.  
Post-induction impeller speed during bioreactor cultivation of each strain is plotted in Figure 
4. Immediately after induction both Fab and Fabi strains show a rapid drop in impeller speed, 
which is expected due to the downshift in oxygen demand characteristic of transition from 
trophophase to carbon-limited, idiophasic growth. For the Fabi strain, impeller speed then 
remains relatively constant until the final stage of the fermentation, 45-50 hours post-
induction when OD600 drops indicating that a large proportion of cells are undergoing 
disintegration and death (Figure 4).  By contrast, for the Fab strain impeller speed steadily 
increases from approximately 10 hours post induction until the maximum attainable speed is 
reached. Maximal impeller speed triggers pure oxygen gas blending to maintain the 30% 
dissolved oxygen tension (DOT) set point (Figure 4). This scenario, of maximal impeller 
speed plus gas blending, persists until the drop in OD600 at 45-50 hours post-induction. 
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These impeller speed profiles suggest a greater number of cell death events occur during 
Fab strain cultivation compared to the Fabi strain. This observation is consistent with the 
greater levels of Fab' leakage observed with the Fab strain being due to lethal outer 
membrane punctures occurring as a result of periplasm overcapacity. 
Differential stain uptake indicates greater cell viability with Ptic promoter compared to 
Ptac 
To test if Fab’ leakage results from lethal outer membrane rupture events we used a flow 
cytometry staining method to calculate the precise number of healthy cells and non-viable, 
permeabilised cells present at different stages of the fermentation. Lewis et al. (25) 
previously, investigating batch fermentation of E. coli in a 5L bioreactor, used bis-oxonol 
(BOX) binding to differentiate between healthy E. coli cells with intact, therefore polarised 
membranes, that do not bind BOX, and cells with de-polarised outer membranes, a marker 
of cell stress, that do bind BOX. In the same study Lewis et al. (25) also used propidium 
iodide (PI) uptake to stain only cells with permeabilised outer membrane. In this way BOX 
plus PI (PIX) analysis by flow cytometry can be used to determine how many cell present in 
a given sample are health, stressed or dead and permeabilised. 
In Figure 5 samples taken at the indicated time points were incubated with PIX and analysed 
by flow cytometry. For each sample analysed by flow cytometry and the number of unstained 
cell and stained cell detection events were logged and then divided by the OD600 of the 
sample in accordance with a procedure performed previously by Volkmer et al. (26). The 
profile of viable cell numbers is mirrored between Fabi and Fab strains, with the difference in 
absolute numbers falling within the variation observed between repeat fermentation runs 
(Figure 5A). After accounting for inter-experiment variation, the Fab strain cultivation still 
produces a far greater number of dead, permeabilised cells compared to the Fabi strain 
(Figure 5B). More than double the number of dead permeable cells is observed in Fab strain 
cultivation compared to the Fabi strain for most time points post induction. 
The ratio of healthy, stressed and permeabilised cells at different stages of the fermentation 
is can also be visualised in the plots of PIX staining in Figure 6. Cultures of both strains 
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consist of approximately 97% healthy cells just prior to induction (Figure 6A and 6B, 0 hours 
post-induction). However, after 35 hours of induction the Fab strain showed a greater 
proportion of stressed (7.1% BOX-only stained) cells (Figure 6) compared to the Fabi strain 
(4.6% BOX-only stained). 35 hours post-induction the proportion of dead, permeablilised 
cells (6.6%) measured for the Fab strain was over double that of the Fabi strain (3.1%). This 
ratio persisted to a degree even at the end of fermentation, when OD600 is dropping, with 
18.1% and 11.6% of Fab strain and Fabi strain cells, respectively, being dead and 
permeabilised.   
 
Conclusions 
We successfully established the Ptic promoter in the pTTOD-A33 Fab’ fragment expression 
plasmid by mutagenesis of the original Ptac promoter (Figure 1), generating the Fabi strain 
and the parental Fab strains respectively. Growth performance of the strains was 
comparable in a 7.5 L bioreactor using an industrial cultivation protocol (Figure 2). 
Conversion of Ptac to Ptic resulted in a 25-35% decrease in Fab’ fragment expression rate 
(Figure 3A), which is comparable to the 35% decrease observed by Brosius et al. (20). 
Relative to the Fab parental strain, decreased intracellular accumulation of Fab’ fragment in 
the Fabi strain was accompanied by decreased appearance of Fab’ fragment in the 
surrounding growth media over the first 40 hours of induction (Figure 3B). This is despite 
almost identical predicted rates of periplasmic filling (Figure 3C). In a previous study (21) 
with the Fab strain we observed that cell debris may sequester Fab’ fragment during 
centrifugation steps in a manner that involves released genomic DNA (Figure 6 of that 
study). We suspect the large proportion of permeabilised cells observed here (Figure 5B) 
may be contributing to the lower than expected level of internal Fab’ measured 55 hours 
post-induction (Figure 3A) and the consequently low level of periplasm occupation by Fab’ 
predicted in the final time point of Figure 3C.  
Indirect evidence, from impeller speed profiles (Figure 4) and PIX staining (Figures 5 and 6), 
indicated that the elevated Fab’ fragment levels in growth media observed in the first 40 
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hours post-induction for the parental Fab strain are likely due to an increased prevalence of 
dead cells in which the integrity and function of the outer membrane have been 
compromised. We conclude that decreasing Fab’ expression by promoter engineering 
results in a decreased cytotoxic burden on the cell, while maintaining growth and productivity 
performance. 
We anticipate that future experiments may establish whether the cytotoxic burdens 
associated with Ptac-drived Fab’ expression are a cause or consequence of the periplasm 
reaching overcapacity. The mechanism of this cytotoxicity is also currently unknown. HPLC 
data gathered during this study and the studies of Balasundaram et al. (24) and Nesbeth et 
al. (21) did not indicate the presence of any significant level of non-dimer or non-monomer 
Fab’ in cell lysates. More direct approaches, such as gel filtration or dynamic light scattering 
(DLS) could better establish the level, if any, of IB-formation for the expressed Fab’ 
fragment. A cytsol-targetted version of the Fab’ fragment in this study could also be used to 
dissect the role of periplasm overcapacity versus global metabolic burden in causing cell 
stress. In the wider context of production and application of antibody-based proteins, we 
suggest a broad palette of cell engineering options should always be considered, such as 
engineered cytosolic disulphide bridge formation (34), plasmid copy number choice, 
antibody-free plasmid retention and promoter engineering. 
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Figure Legends 
Figure 1. Ptac and Ptic promoters. Schematic representation of Ptac and Ptic promoters 
(panel A), and specific base insertions (panel B). The Ptic insertion was made by site directed 
mutagenesis and increases the gap between the -10 and -35 sites by two bases 
(underlined). 
 
Figure 2. Growth of Fabi and Fab strains in 7.5 L fed-batch fermentation. Seed trains 
were prepared by inoculating 200 mL selective LB media in a 1 L shake flask with a single, 
600 µL working cell bank stock. This culture was grown until an OD600 of 1.0 was reached, 
where a 40 mL aliquot was removed and used to inoculate 360 mL selective defined media. 
This culture was then grown to an OD600 of 5.0, then used to inoculate 3.4 L of defined media 
without antibiotic in a 7.5 L bioreactor, giving a final volume of 4 L and starting OD600 of 0.75. 
A previously described protocol (24) was scaled for use at this scale. Error bars indicate 
standard deviation over n=3 measurements. 
 
Figure 3. Intracellular, extracellular and periplasmic accumulation of Fab’ fragment. At 
the end of trophophasic growth cells were induced by addition of 10 mL 15.31 g/L IPTG, and 
then fed 80% glycerol at a rate of 6.4 mL/hour until fermentation end. Following the 
previously described protocol (21), post induction Fab’ production was measured by protein 
G HPLC, and extracellular and total Fab’ levels were measured to allow the calculation of 
intracellular Fab’. Intracellular Fab’ levels were plotted in graph A. Extracellular Fab’ levels 
were plotted for 60 hours post induction (graph B, larger graph) and only the first 40 hours 
(graph B, inlaid graph). Percentage of total periplasm volume predicted by Equation 1 to be 
occupied by Fab’ was plotted in graph C. Data sets shown are indicative of n=3 
measurements. Error bars indicate standard deviation over n=3 measurements which was 
<5% for all data points so error bars fall within marker symbols. 
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Figure 4. Post induction impeller speed and gas blending. Impeller speeds and gas 
mixing post induction are plotted. A target level of 30% dissolved oxygen tension was set for 
the bioreactor control unit.  
 
Figure 5. Physiological status of cells post-induction. Unstained cell and stained cell 
detection events in a given sample were divided by the OD600 of the sample in accordance 
with a procedure performed previously by Volkmer et al. (26). Error bars indicate standard 
deviation over n=2 measurements. 
 
Figure 6. Cellular PIX staining profiles post-induction. Post induction PI / BOX (PIX) 
staining profiles, as measured by flow cytometry, of Fab (A) and Fabi (B) strains after zero, 
35 and 54 hours post-induction. For each profile the lower left quadrant is gated as zero PIX 
staining and indicates healthy cells. Staining with PI only (upper left quadrant) is attributed to 
fragments and other debris. Staining with BOX only (lower right quadrant) indicates cells 
undergoing stress and cells stained with both BOX and PI (upper right quadrant) are both 
non-viable (dead/dying) and permeabilised. Data sets shown are indicative of n=2 
measurements. 
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TTGACAA TATAAT Fab’ 16 10 ATG 
TTGACAA TATAAT Fab’ 18 10 ATG 
tac 
tic 
TTGACAATTAATCAT!!CGGCTCGTATAATGTGTGGAA Ptac 
-35 -10 
TTGACAATTAATCATCGCGGCTCGTATAATGTGTGGAA Ptic 
-10 -37 
Page 21 of 26
John Wiley & Sons
Biotechnology Progress
This article is protected by copyright. All rights reserved.
!"
#!"
$!"
%&!"
%'!"
!" &!" #!" '!" $!" %!!" %&!"
&'()%*+,-.%/0-1%'203456702%
()*+" ()*" Page 22 of 26
John Wiley & Sons
Biotechnology Progress
This article is protected by copyright. All rights reserved.
!"
#"
$!"
$#"
!" %!" &!" '!"
23.)%-4+51%
()*+" ()*"
6%
!"
#"
$!"
$#"
!" %!" &!" '!"
!"
#$
%&
'(
&)
(*
+"
,'
(%
-.
/0
/1
%
23.)%-4+51%
()*+" ()*"
7%
!"
%"
&"
'"
,"
!" %!" &!" '!"
8)
+&
)(
*"
/)
%'
&&
9:
"(
&;
%-<
1%
23.)%-4+51%
()*+" ()*"
=%
!"
#"
$"
%"
!" #!" $!" %!" &!" '!"
Page 23 of 26
John Wiley & Sons
Biotechnology Progress
This article is protected by copyright. All rights reserved.
!"
#"
$!"
$#"
!"
%!!"
&!!"
$'!!"
$(!!"
!" '!" %!" (!"
!"
#$
"%
&'
("
)*
+,
("
%)
-.
"%
/0
%(
)12
3)
45
6"
.."
#)7
6"
"/
)18
!9
3)
:05")1;#73)
)*+," )*+" )*+"-./012"+3124"
Time (hrs) post induction 
Page 24 of 26
John Wiley & Sons
Biotechnology Progress
This article is protected by copyright. All rights reserved.
Page 25 of 26
John Wiley & Sons
Biotechnology Progress
This article is protected by copyright. All rights reserved.
0 35 54 
Time (hrs) 
Post-Induction 
P
I S
ta
in
in
g 
BOX Staining 
B 
Page 26 of 26
John Wiley & Sons
Biotechnology Progress
This article is protected by copyright. All rights reserved.
